Fund moves
5.7%Stake
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jul 7, 2026 · Filed Jul 9, 2026
The CEO of ResMed| sold $1.09M of ResMed| shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$1,090,771
Shares × reported transaction price
on the day of results (Jul 7, 2026), 30 days before results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $219.75 on Jul 7, 2026, 20% above its 52-week low and 25% below its high, after a 5% rise over the previous 30 trading days
52-week range $182.82 (Jun 2, 2026) to $293.73 (Aug 22, 2025), 33% of the way up, from 251 adjusted closes. 30 trading days earlier: $208.98 on May 21, 2026. Describes the past only, not a forecast
RSI 69, 8% under its 200-day average, 9% above its 50-day average, 25% below the 52-week high, 20-day volatility 33% a year, against the S&P 500: +14 points over 1 month, −16 points over 3 months, −20 points over 6 months
From the adjusted closes up to Jul 7, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −2.4% | −1.5% | −0.8% |
| 30 days | +7.9% | +2.4% | +5.5% |
| 90 days | +11.2% | +2.5% | +8.7% |
Past results only. Not a forecast.
Fund moves
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Peter C Farrell (Director) sold ~$1.8M of ResMed|
Planned saleCongress
Traded May 3, 2024 · disclosed 824 days laterLate
Held by the filer's joint per the disclosure.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.